Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-26-426810

Chief Legal Officer sold 1,635 shares at $12.84 ($20,993)

  • Chief Legal Officer acquired 1,635 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bizily Scott · Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-16 Exercise or conversion : show line 1 in the form 10b5-1 +1,635 $4.14 $6,769 10,252 D
2026-10-16 Sale : show line 2 in the form 10b5-1 −1,635 $12.84 $20,993 8,617 D
Open-market sales · 1,635 sh · avg $12.84 · $20,993

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-16 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −1,635 56,431 D
Loading xslF345X06/ownership.xml…